1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: November 2-8, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: November 2-8, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 11/04/2025
Location: Washington, DC
Subject: Generic Drug Supply Chain
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Kathleen Jaeger (Center for American Medicine Resiliency); George Zorich (Nevakar, Inc.);

Event Date: 11/05/2025
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Richard Hudson, (R-NC)

Event Date: 11/05/2025
Location: Silver Spring, MD
Subject: Policy Reform Opportunities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Andreessen Horowitz representatives

Event Date: 11/06/2025
Location: Washington, DC
Subject: 2025 Milken Institute Future of Health Summit; Speaker: A Conversation with FDA Commissioner
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Event Date: 11/08/2025
Location: Arlington, VA
Subject: FDA Leadership and Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry and government

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

Event Date: 11/06/2025
Location: Silver Spring, MD
Subject: FDA Digital Health Advisory Committee Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

No Significant Event

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 11/06/2025
Location: Silver Spring, MD
Subject: Collaboration Opportunities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: FidoCure representatives

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: George F. Tidmarsh, M.D., Ph.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

Event Date: 11/04/2025
Location: Virtual
Subject: National Association of Attorneys General 2025 Master Settlement Agreement Triennial Conference
FDA Participant/Group: JOHN VERBETEN; 
Non FDA Participant/Group: Industry, academia, government, and other registered attendees

Event Date: 11/06/2025
Location: Silver Spring, MD
Subject: Tobacco Product Innovation and Proposed FDA Process Improvements
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Elizabeth Copeland, K.C. Crosthwaite, Kirk Phelps, Michael Fisher, Robyn Gougelet (Juul Labs, Inc.);

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top